ArticleJournal for immunotherapy of cancer2026

First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study.

Casey Bermack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.